
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
OncoSil Medical Ltd | ASX:OSLO | Australian Stock Exchange | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.001 | 0.001 | 0.001 | 0.00 | 00:00:00 |
The London Stock Exchange said Thursday that it and Oslo Bors have entered into a strategic partnership agreement to co-operate across their equities, fixed income and derivatives markets with a view to improving market efficiency and liquidity.
As part of the agreement, London Stock Exchange Group will provide Oslo Bors with TradElect for its equities and fixed income markets and the SOLA trading platform, under licence from TMX Group, for its derivatives markets.
The migration of the Oslo Bors cash equities and fixed income markets to TradElect will take place in the first quarter of 2010, subject to client readiness.
The migration of the Oslo Børs and EDX derivatives market will take place in November, subject to client readiness, the LSE said.
The two companies also anticipate co-operation in areas such as regulatory policy, operational regulatory processes and the sharing of market information for regulatory purposes.
1 Year OncoSil Medical Chart |
1 Month OncoSil Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions